Weiming Lv

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Prognostic Factors

Papillary Thyroid

Sentinel Lymph Node

Top Venues

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Shubin Hong, Yubin Xie, Zhen Cheng, Jie Li, Weiman He, Zhuming Guo, Quan Zhang, Sui Peng, Minghui He, Shuang Yu, Lixia Xu, Rengyun Liu, Tianyi Xu, Yunjian Zhang, Yanbing Li, Ji-Guang Wang, Weiming Lv, Jun Yu, Hai-Peng Xiao
Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability. Oncogene 41 (47) (2022)
Shuang Yu, Changan Liu, Yingtong Hou, Jie Li, Zhuming Guo, Xinwen Chen, Luyao Zhang, Sui Peng, Shubin Hong, Lixia Xu, Xiaoxing Li, Rengyun Liu, Shuwei Chen, Bin Li, Zongpeng Weng, Yanbing Li, Weiming Lv, Jun Yu, Hai-Peng Xiao
Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer. Oncogene 41 (17) (2022)
Zeng Fang, Ruizhi Wang, Ciqiu Yang, Dong Wang, Wanna Chen, Bo Lin, Dongsheng Gong, Songqi Li, Jiadong Liang, Xiaoli Liang, Chunxian Zeng, Jie Li, Kun Wang, Weiming Lv
A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases. Disease markers 2021 (2021)